EU to decide on Alexion-AstraZeneca deal by July 5

Tuesday, 01. June 2021 12:03

The European Union's antitrust authority is expected to decide about greenlighting AstraZeneca's $39 billion acquisition of Alexion Pharmaceuticals by July 5, according to a filing revealed on Tuesday.

The European Commission has options to approve the merger or launch an investigation up to four-month-long if some concerns arise. Next to Brussels, the United Kingdom has also been reviewing the agreement, while the United States, Russia, Canada and Brazil already approved it.

AstraZeneca first announced the deal last December, estimating the merger process should be finalized by the third quarter of 2021.

Related Links: AstraZeneca plcAlexion Pharmaceuticals Inc.
Breaking the News / ND